News|Articles|May 15, 2015
- Pharmaceutical Technology-05-15-2015
- Volume 2015 eBook
- Issue 2
Controlled Nucleation for a Monoclonal Antibody Formulation—A Case Study
Author(s)Joseph Brower, Eugene Wexler, PhD
This study evaluates the impact of controlled nucleation on the ability to optimize a lyophilization cycle for a monoclonal antibody formulation.
Advertisement
This study evaluates the impact of controlled nucleation on the ability to optimize a lyophilization cycle for a monoclonal antibody formulation.
Download
Articles in this issue
over 10 years ago
Validating and Implementing a Rapid Sterility Testing Methodover 10 years ago
Cleanroom and Facility Planning: Getting Beyond Cost Per Square Footover 10 years ago
Aging Facilities: Aseptic Manufacturing Faces the FutureNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
2
Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment
3
Drug Digest: Closing the Gap in Modern Process Control and Automation for QC/QA
4
BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation
5
